Trying to learn how to translate from the human translation examples.
From professional translators, enterprises, web pages and freely available translation repositories.
beetablokaatorite toksilisus tuleneb nende ülemäärasest terapeutilisest toimest:
the toxicity of beta-blockers is an extension of their therapeutic effects:
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
soovitatud terapeutilisest annusest suuremate annuste kasutamise kogemus on vähene.
experience with doses higher than the recommended therapeutic dose is limited.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
alla 1% amprenaviiri terapeutilisest annusest eritub muutumatul kujul uriiniga.
less than 1 % of the therapeutic dose of amprenavir is excreted unchanged in the urine.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
ic50 oli ligikaudu üheksa korda kõrgem maksimaalsest terapeutilisest vaba ravimi kontsentratsioonist.
the ic50 was approximately nine-times above the maximum therapeutic free concentration.
Last Update: 2012-04-11
Usage Frequency: 2
Quality:
süsteemsel manustamisel ja terapeutilisest annusest suuremates doosides kasutamisel seostatakse gentamütsiini ototoksilisusega.
gentamicin is known to be associated with ototoxicity when administered by the systemic route at higher doses.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
selle toote toimet ei saa võrrelda teise samast terapeutilisest klassist pegileeritud või pegileerimata proteiiniga.
the potency of this product should not be compared to the potency of another pegylated or non- pegylated protein of the same therapeutic class.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
küülikutel katkes tiinus koos emale avalduva toksilisusega ekspositsioonidel, mis olid inimese terapeutilisest vahemikust madalamad.
in rabbits abortion occurred in conjunction with maternal toxicity at exposures below the human therapeutic range.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
terapeutilisest annusest mitu korda suuremates annustes hüdroksükarbamiidi saanud patsientidel on täheldatud ägedat toksilisust naha ja limaskestade suhtes.
acute mucocutaneous toxicity has been reported in patients receiving hydroxycarbamide at doses several times above the therapeutic dose.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
everoliimus avaldas terapeutilisest tasemest väiksemate annuste süsteemse ekspositsiooni korral roti embrüole / lootele toksilist toimet.
in rats, everolimus caused embryo/foetotoxicity at systemic exposure below the therapeutic level.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
annuste vaheajal säilisid eksenatiidi ühtlased kontsentratsioonid ühe nädala jooksul, minimaalse tippkontsentratsiooniga ja kergete kõikumistega keskmisest terapeutilisest kontsentratsioonist.
steady-state exenatide concentrations are maintained during the one-week interval between doses with minimal peak to trough fluctuation from this average therapeutic concentration.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
atosibaani suurim nahaalune annus, mis ei tekitanud mingeid kõrvaltoimeid, oli peaaegu kaks korda suurem inimesele manustatavast terapeutilisest annusest.
the highest atosiban subcutaneous dose not producing any adverse effects was approximately two times the therapeutic human dose.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
kartsinogeensus kartsinogeensust ei ilmnenud, kui hiirtele manustati maksimaalne talutav annus, mis oli umbes 2... 3 korda suurem terapeutilisest annusest.
carcinogenicity no carcinogenicity was noted in mice at the maximum tolerated dose, which corresponded to a systemic exposure approximately 2 to 3 times higher than the clinical exposure.
Last Update: 2012-04-11
Usage Frequency: 6
Quality:
on täheldatud üleannustamist, k.a üks patsient, kellele lühikese aja jooksul manustati blincyto soovitatud terapeutilisest annusest 133 korda suurem annus.
overdoses have been observed including one patient who received 133-fold the recommended therapeutic dose of blincyto delivered over a short duration.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
kõik peale ühe nendest patsientidest saavutasid tühja kõhuga terapeutilisest läviväärtusest (100 ng/ml) kõrgemad sakvinaviiri cmin väärtused.
all but one of the patients achieved ctrough values of saquinavir above the therapeutic threshold (100 ng/ml) in the fasted state.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
kokihaigetel seostati maksimaalsest soovitatavast terapeutilisest annusest 10 korda suuremaid ühekordseid annuseid pulsisageduse mõõduka kiirenemise, süstoolse vererõhu mõõduka tõusu ja qtc-intervalli mõõduka pikenemisega.
in copd patients, single doses of 10 times the maximum recommended therapeutic dose were associated with a moderate increase in pulse rate, systolic blood pressure and qtc interval.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
verevalkudega seondumata kontsentratsioon, mis on tavaliselt vähem kui 1% linagliptiini terapeutilisest annusest, suurenes pärast ritonaviiri samaaegset manustamist 4…5 korda.
the unbound concentrations, which are usually less than 1% at the therapeutic dose of linagliptin, were increased 4-5-fold after co-administration with ritonavir.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
koostoimetest tingitud ekspositsiooni suurenemise ulatus ei tõstata ohutusalaseid küsimusi, kuna hirobriz breezhaler’i kasutamine kliinilistes uuringutes kuni ühe aasta vältel maksimaalsest soovitatavast terapeutilisest annusest kuni kaks korda suuremates annustes oli ohutu.
the magnitude of exposure increases due to interactions does not raise any safety concerns given the safety experience of treatment with hirobriz breezhaler in clinical studies of up to one year at doses up to twice the maximum recommended therapeutic dose.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
radioaktiivset sm-edtmpd ei ole uuritud mutageensuse/kartsinogeensuse suhtes, kuid seoses terapeutilisest ekspositsioonist saadava kiirgusdoosiga tuleb seda vaadelda kui genotoksilise/kartsinogeense riski allikat.
radioactive sm-edtmp has not been tested for mutagenicity/carcinogenicity but due to the radiation dose resulting from therapeutic exposure it should be regarded as presenting a genotoxic/carcinogenic risk.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
hambaarstile hammaste, suu, lõualuude ja kaasnevate kudede anomaaliatest, kahjustustest ja haigustest, samuti ennetavast, diagnostilisest ja terapeutilisest hambaarstitööst täielikku pilti andvate kliiniliste distsipliinide ja meetodite piisav tundmine;
adequate knowledge of clinical disciplines and methods, providing the dentist with a coherent picture of anomalies, lesions and diseases of the teeth, mouth, jaws and associated tissues and of preventive, diagnostic and therapeutic dentistry;
Last Update: 2014-11-21
Usage Frequency: 1
Quality:
küülikutel seostati lapatinibi annuseid 60 ja 120 mg/kg päevas (vastavalt 8% ja 23% eeldatavast terapeutilisest annusest) emaslooma mürgistusega ning annust 120 mg/kg päevas abordiga.
in rabbits, lapatinib was associated with maternal toxicity at 60 and 120 mg/kg/day (8% and 23% of the expected human clinical exposure, respectively) and abortions at 120 mg/kg/day.
Last Update: 2017-04-26
Usage Frequency: 3
Quality: